neonatal abstinence syndrome Archives
Apr. 15, 2016—Standardizing hospital care policies across institutions for infants diagnosed with drug withdrawal symptoms at birth reduces their length of treatment and hospitalization, according to new research led by Vermont Oxford Network, Vanderbilt and the University of Michigan Health System.
Oct. 1, 2015—Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.
Jun. 29, 2015—Stephen Patrick, M.D., MPH, assistant professor of Pediatrics and Health Policy in the Division of Neonatology with the Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently testified before congress about the rise in neonatal abstinence syndrome.
Vanderbilt study finds babies exposed to narcotic pain relievers more likely to experience drug withdrawal syndrome
Apr. 13, 2015—Legally prescribed narcotics taken during pregnancy can lead to neonatal abstinence syndrome, especially in combination with tobacco or SSRIs.
Jul. 17, 2014—In the United States, one infant is born each hour with drug withdrawal, known as neonatal abstinence syndrome (NAS), after being exposed to opioid medications like oxycodone in utero.